Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

657
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
657
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

173
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
173
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

196
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
196
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac remodelling and clinical outcomes after mitral edge-to-edge repair with the PASCAL® system.

European heart journal. Imaging methods and practice·2026
Same author

Impact of Adverse Events on Costs and Length of Stay Following Transcatheter Tricuspid Valve Replacement.

Structural heart : the journal of the Heart Team·2026
Same author

Right Ventricular Function and Echocardiographic Characteristics After Left Atrial to Coronary Sinus Shunting; Insights from ALT-FLOW Early Feasibility Study 3 Year Follow-Up.

Journal of cardiac failure·2026
Same author

Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Transcatheter Aortic Valve Replacement: A Real-World Propensity-Matched Analysis.

Structural heart : the journal of the Heart Team·2026
Same author

Predicted versus observed outcomes in the ALT-FLOW early feasibility study.

ESC heart failure·2026
Same author

Impact of Residual Mitral Regurgitation and Gradient After M‑TEER: 1‑Year Outcomes From the CLASP IID Trial.

JACC. Cardiovascular imaging·2026

Related Experiment Video

Updated: Jan 2, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K

Meta-Analysis Comparing Complete Versus Infarct-Related Artery Revascularization in Patients With ST-Elevation

Mohammed Osman1, Safi U Khan1, Peter D Farjo1

  • 1Division of Cardiology, West Virginia University School of Medicine, Morgantown, West Virginia.

The American Journal of Cardiology
|December 9, 2019
PubMed
Summary

Complete revascularization (CR) significantly reduces major adverse cardiovascular events (MACE) in ST-elevation myocardial infarction (STEMI) patients compared to infarct-related artery revascularization (IRA). This benefit is primarily driven by lower rates of repeat revascularization in the CR group.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.5K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.2K

Related Experiment Videos

Last Updated: Jan 2, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.5K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.2K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • The optimal revascularization strategy for ST-elevation myocardial infarction (STEMI) remains debated.
  • Complete revascularization (CR) aims to address all significant coronary stenoses, while infarct-related artery revascularization (IRA) focuses on the culprit lesion.

Purpose of the Study:

  • To conduct an updated meta-analysis comparing CR versus IRA in STEMI patients.
  • To evaluate the impact of these strategies on major adverse cardiovascular events (MACE) and other clinical outcomes.

Main Methods:

  • Systematic review and meta-analysis of ten randomized controlled trials.
  • Inclusion of 7,423 patients with STEMI, comparing CR (3,574 patients) and IRA (3,849 patients).
  • Follow-up duration of 2.0 ± 0.8 years, assessing MACE, mortality, stroke, repeat revascularization, myocardial infarction, and contrast-induced nephropathy.

Main Results:

  • CR significantly reduced MACE compared to IRA (10.7% vs 18.6%, RR 0.64, p=0.002).
  • CR was associated with substantially lower rates of repeat revascularization (4.0% vs 11.7%, RR 0.44, p<0.0001).
  • No significant differences were observed in all-cause mortality, myocardial infarction, stroke, or contrast-induced nephropathy between the groups.

Conclusions:

  • Complete revascularization (CR) is associated with a significant reduction in major adverse cardiovascular events (MACE) in STEMI patients compared to infarct-related artery revascularization (IRA).
  • The observed benefit of CR is primarily attributed to a significant decrease in repeat revascularization rates.
  • CR represents a favorable strategy for STEMI management, particularly in reducing the need for subsequent procedures.